Le Lézard
Classified in: Health, Business
Subjects: LIC, DIS, DEI

Elevate Dynamics' AFO1tm Products Will Benefit Patients Internationally


SAN DIEGO, Dec. 14, 2021 /PRNewswire/ -- Elevate Dynamics has entered into two new supplier agreements, making its next generation medical devices available internationally. Head to Foot Orthotics (HTFO) in Australia and New Zealand, and Medlines Inc. in Canada are now the exclusive suppliers of Elevate's AFO1TM product line to treat foot drop caused by a variety of neurologic and musculoskeletal disorders.

"Expanding our technology to Australia, New Zealand and Canada means making a positive impact in so many more lives. Our partners at HTFO and Medlines bring experience, a customer-centric mindset and a passion for their market that we trust and believe in," said Jason Thorne, CEO of Elevate Dynamics. "We are committed to our vision of empowering a healthy world through movement and believe that these new partners are an important step for us to create the necessary global access to our solutions."

Elevate's AFO1TM products include its FreeFlow, Glide, and HelixBand, which deliver an improved patient experience and enhance clinic operations. An industry-first all-sizes-in-one design permits clinicians to comfortably fit a wide range of patients while significantly reducing inventory complexity. 

"We're looking forward to working with the team at Elevate to bring a range of high quality, patient-centric solutions to the Australian and New Zealand market," said Stephen Dickins and Tim Jarrott, directors and chief product officers of HTFO.

"We are extremely excited to partner with Elevate Dynamics and launch their AFOs to the Canadian marketplace. The team at Elevate is extremely talented and has a long and successful track record in the international O&P communities," said Brett Holmes, president of Medlines. "We are confident that their new and innovative AFO products will provide the Canadian O&P professionals with enhanced tools to address their patient's needs."

About HTFO
Head to Foot Ortho (HTFO) provides both clinical orthotic care and wholesale products with a focus on achieving optimal patient outcomes. Owned and operated by clinical orthotists, HTFO provides a comprehensive clinical orthotics service across Australia and New Zealand with a range of unique, innovative healthcare products. The HTFO team is vibrant, energetic and highly experienced, allowing us to provide the best care and service available. For more information, please visit htfo.com.au

About Medlines
Medlines Inc. is a Canadian distributor of medical devices based in Calgary, Alberta. We have been serving the Canadian orthopedic and sports medicine community since 2001. We represent and support innovative products and solutions in the area of musculoskeletal care and pain management. Having established collaborative relationships with our manufacturing partners, allows us to provide our customers with state-of-the-art devices and technologies. Learn more at https://medlines.ca/about-us/

About Elevate
Elevate is a next generation medical device company. Our mission is to empower people to move by redefining how healthcare products are designed, manufactured, and delivered. Our approach focuses on novel products and innovative solutions that elevate patient care and experience, and address issues impacting healthcare providers and their patients. Our team is dedicated to making the best products and leaving the world a better place than we found it. For additional information, please visit Elevate's website at www.elevatemovement.com.

Media Contact:
Jane Edwards
Customer Experience Director, Elevate Dynamics
U.S. 339.933.9422
[email protected] 

SOURCE Elevate Dynamics


These press releases may also interest you

at 02:30
Ahead of International Tea Day - 21st May 2024  - and with summer inspiring more of us to get off the sofa to be active, a 2024 real-world research study1 reviewed by the tea science experts at the Tea Advisory Panel ? www.teaadvisorypanel.com -...

at 02:30
TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson's disease cell therapy program, which has demonstrated excellent results with full motor recovery at 16 weeks in preclinical studies.[1]...

at 02:20
Vicore Pharma Holding (STO:VICO)Buloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment.The therapy was safe and well tolerated with no treatment-related serious adverse events.Biomarker analysis...

at 02:07
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....

at 02:05
PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announces the opening of its proposed $100 million tender offer (the "Tender...

at 01:30
The global urinary catheters market  size is estimated to grow by USD 2.44 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 7.63%  during the forecast period. ...



News published on and distributed by: